Ep40: Taking DTx to Market: Nate Beyor Gives Insights On Building Teams and Products

Sep 20, 2022

30:18

forum

Ask episode

view_agenda

Chapters

auto_awesome

Transcript

info_circle

Episode notes

In this episode, we hear from Nate Beyor, managing director and partner of BCG healthcare. We dive into many topics around digital therapeutics and get a bird's eye view across BCG's customer base.

In this episode, we cover:

New company creation: large company spin-outs vs entrepreneurs
What it takes to build a team that can take a digital therapeutic to market
Why build rather than buy a new DTx
Approaching medical pharma clients vs approaching smaller DTx companies
Go to market strategy and value creation: Standalone vs Drug+
Embedding clinical decision support into workflows

Guest Links and Resources:

Connect with Nate Beyor on: LinkedIn
Visit: www.bcg.com/

Host Links:

Connect with Eugene Borukhovich: Twitter | LinkedIn
Connect with Chandana Fitzgerald, MD: Twitter | LinkedIn
Connect with YourCoach.health: Website | Twitter
Check out Shot of Digital Health with Eugene and Jim Joyce: Website | Podcast App
HealthXL: Website | Twitter | Join an Event

Season 2 of Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to:

> Presenting Partner: Amalgam Rx

> Contributing Sponsors: Akili | Big Health | Click Therapeutics | Lindus Health